NVAX Novavax, Inc. Stock Quote

NVAX [NASD]

Index	-	P/E	-	EPS (ttm)	-6.79	Insider Own	0.20%	Shs Outstand	65.79M	Perf Week	26.49%
Market Cap	14.93B	Forward P/E	6.92	EPS next Y	32.84	Insider Trans	-55.90%	Shs Float	62.53M	Perf Month	0.84%
Income	-418.30M	PEG	-	EPS next Q	-2.65	Inst Own	53.20%	Short Float	6.87%	Perf Quarter	74.91%
Sales	475.60M	P/S	31.38	EPS this Y	-32.00%	Inst Trans	25.88%	Short Ratio	0.99	Perf Half Y	103.43%
Book/sh	9.53	P/B	23.86	EPS next Y	65.68%	ROA	-44.20%	Target Price	300.75	Perf Year	1156.08%
Cash/sh	10.83	P/C	20.99	EPS next 5Y	0.00%	ROE	-187.10%	52W Range	16.41 - 331.68	Perf YTD	103.88%
Dividend	-	P/FCF	-	EPS past 5Y	9.50%	ROI	-38.00%	52W High	-33.12%	Beta	1.46
Dividend %	-	Quick Ratio	2.20	Sales past 5Y	67.30%	Gross Margin	-	52W Low	1251.80%	ATR	16.75
Employees	791	Current Ratio	2.20	Sales Q/Q	3072.20%	Oper. Margin	-87.60%	RSI (14)	59.62	Volatility	8.97% 8.80%
Optionable	Yes	Debt/Eq	0.75	EPS Q/Q	-138.40%	Profit Margin	-87.90%	Rel Volume	0.67	Prev Close	227.35
Shortable	Yes	LT Debt/Eq	0.58	Earnings	Mar 01 AMC	Payout	-	Avg Volume	4.35M	Price	221.83
Recom	2.00	SMA20	15.39%	SMA50	1.43%	SMA200	53.91%	Volume	2,719,245	Change	-2.43%

Dec-14-20

Initiated

Jefferies

Buy

$200

Aug-06-20

Reiterated

H.C. Wainwright

Buy

$132 → $290

Aug-05-20

Upgrade

JP Morgan

Neutral → Overweight

$275

Aug-05-20

Downgrade

Ladenburg Thalmann

Neutral → Sell

$105

Jul-16-20

Reiterated

H.C. Wainwright

Buy

$101 → $132

Jul-08-20

Downgrade

Ladenburg Thalmann

Buy → Neutral

$50 → $105

Jun-29-20

Reiterated

H.C. Wainwright

Buy

$50 → $101

Jun-29-20

Reiterated

B. Riley FBR

Buy

$74 → $106

Jun-05-20

Upgrade

JP Morgan

Underweight → Neutral

$46

May-28-20

Reiterated

B. Riley FBR

Buy

$53 → $61

May-12-20

Reiterated

H.C. Wainwright

Buy

$33 → $50

Apr-30-20

Reiterated

H.C. Wainwright

Buy

$24 → $33

Nov-27-19

Resumed

B. Riley FBR

Buy

$12

Aug-14-19

Reiterated

H.C. Wainwright

Buy

$10 → $17

Feb-28-19

Downgrade

Piper Jaffray

Overweight → Underweight

$4.50 → $0.25

Dec-18-18

Initiated

Ladenburg Thalmann

Buy

Dec-11-18

Initiated

Oppenheimer

Outperform

Nov-26-18

Upgrade

Piper Jaffray

Neutral → Overweight

Sep-21-18

Upgrade

JP Morgan

Underweight → Overweight

Mar-29-18

Upgrade

Seaport Global Securities

Neutral → Buy

Apr-19-21 01:49PM	Doctor on J&J vaccine: You have a much higher risk of getting a blood clot if you smoke Yahoo Finance Video
06:00AM	The Moderna CEO's Bold Statement That May Mean Bad News for Novavax Motley Fool
Apr-17-21 09:26AM	Novavax Is Missing Out on a Big Deal Motley Fool
08:23AM	Moderna cuts UK COVID vaccine deliveries as pregnant women told mRNA jabs are safe Yahoo Finance UK
Apr-16-21 02:57PM	The push to vaccinate farm workers against COVID-19 Yahoo Finance Video +12.50%
01:53PM	Vaccinating kids will be very important in getting to herd immunity: Expert Yahoo Finance Video
09:23AM	Pfizer CEO says a third vaccine dose is likely, Moderna updates booster shot timeline Yahoo Finance Video
09:22AM	Buy Novavax Because It Could Be About to Score With J&Js Covid-19 Vaccine on the Sidelines Barrons.com
06:30AM	3 Biotech Stocks Ripe for Spring Portfolio Cleaning Motley Fool
Apr-15-21 05:45PM	Novavax (NVAX) Gains But Lags Market: What You Should Know Zacks
04:43PM	How J&J's Coronavirus Vaccine Fiasco Could Benefit Novavax And Others Investor's Business Daily
03:13PM	More domestic medical supply manufacturing is critical for the U.S. : Premier President Yahoo Finance Video
02:04PM	FDA, CDC precaution with vaccine side effects is encouraging: Doctor Yahoo Finance Video
09:20AM	Global COVID-19 vaccine supply "incredibly tight", COVAX needs funds - Gavi Reuters
07:49AM	The Daily Biotech Pulse: Merck Shelves 2 COVID-19 Studies, Bristol-Myers Squibb Gets European Regulatory Nod, InspireMD's Reverse Split Benzinga
06:09AM	How Soon Will Novavax File for Emergency Use Authorization for Its COVID Vaccine? Motley Fool
Apr-14-21 05:39PM	Novavax to Participate in University of Oxford Com-COV2 Study Comparing Mixed COVID-19 Vaccine Combinations PR Newswire
02:46PM	Johnson & Johnsons Vaccine Pain Could Be Modernas and Pfizers Vaccine Gain TipRanks
02:11PM	Vaccine transparency is the best course of action: Doctor Yahoo Finance Video
01:43PM	U.S. in unique position to force increased accountability at the WHO: FDD Yahoo Finance Video
12:23PM	Why Novavax Stock Is Jumping Again Today Motley Fool
11:02AM	Moderna is committed to keep chasing new COVID variants: CEO Yahoo Finance Video
09:34AM	Is J&J's COVID-19 Vaccine Setback a Boon for Other Players? Zacks
09:13AM	UK Trial On Mix-Match COVID-19 Vaccines Expanded To Add Moderna, Novavax Shots Benzinga
07:00AM	Is Novavax Stock A Buy On Its Leading Covid Vaccine Effectiveness? Investor's Business Daily
06:31AM	Why Are Participants in Novavax's COVID Vaccine Study Receiving 2 Extra Shots? Motley Fool
06:01AM	3 Stocks to Buy That Wall Street Thinks Will Soar 50% or More Motley Fool
05:35AM	Moderna and Novavax added to mix and match COVID-19 vaccine trial MarketWatch
Apr-13-21 07:01PM	UK trial on switching COVID-19 vaccines adds Moderna and Novavax shots Reuters +10.82%
05:52PM	Novavax CFO to step down, biotech company says MarketWatch
05:34PM	Novavax Announces Leadership Updates PR Newswire
02:09PM	Doctor on J&J vaccine pause: CDC is letting the public know they are taking any side effect seriously Yahoo Finance Video
11:00AM	Why Novavax and BioNTech Stocks Are Jumping Today Motley Fool
09:28AM	FDA, CDC recommend pause in Johnson & Johnson COVID-19 vaccine Yahoo Finance Video
06:00AM	Novavax says supply shortages delaying full-speed production of its COVID-19 vaccine Reuters
Apr-12-21 01:51PM	Id still trust vaccines to suppress emergence of more variants: Doctor Yahoo Finance Video
Apr-11-21 06:04AM	Is Novavax Actually a Value Stock? Motley Fool
Apr-10-21 09:03AM	How Important Is Novavax's COVID Vaccine Manufacturing Deal With GlaxoSmithKline? Motley Fool
06:30AM	3 Stocks That Could Suffer if Biden Gives In to This Pressure Motley Fool
05:56AM	3 Biotech Stocks With Big Catalysts Around the Corner Motley Fool
Apr-09-21 10:59PM	Novavax: All Eyes on Upcoming Phase 3 PREVENT-19 Study Readout TipRanks
05:45PM	Novavax (NVAX) Outpaces Stock Market Gains: What You Should Know Zacks
01:39PM	Pfizers vaccine EUA expansion request is extremely welcomed: Doctor Yahoo Finance Video
06:06AM	5 Growth Stocks With 43% to 70% Upside, According to Wall Street Motley Fool
Apr-08-21 05:00PM	Top COVID-19 Vaccine Stories of March Put Biotech ETFs in Focus Zacks
03:23PM	Study shows wearables could detect COVID-19 earlier Yahoo Finance Video
01:23PM	COVID-19 vaccinations are extraordinarily safe: Doctor Yahoo Finance Video
08:05AM	Novavax to Participate in Fireside Chat at Goldman Sachs Virtual Conference PR Newswire
Apr-07-21 05:12PM	Is NVAX Stock A Buy or Sell? Insider Monkey
01:26PM	COVID-19 mitigation is the most effective weapon to avoid fourth wave: Doctor Yahoo Finance Video
11:01AM	White House wont support vaccine passports: Psaki Yahoo Finance Video
09:36AM	Company News for Apr 7, 2021 Zacks
07:00AM	This Vaccine Maker May Be Next to Go After the Kids' Market Motley Fool
Apr-06-21 02:43PM	Biotech company Kaleido develops oral therapy for COVID-19 Yahoo Finance Video
01:29PM	Theres increasing confidence vaccine supply can meet demand: Doctor Yahoo Finance Video
11:09AM	The next few weeks 'are going to be critical,' Fauci warns Yahoo Finance
08:04AM	The Daily Biotech Pulse: Illumina Lights Up, Cara Soars On Index Inclusion, Novavax Starts Crossover Vaccine Study, Turning Point Data Readout Benzinga
07:29AM	Novavax Allows Participants On Placebo Arm To Get COVID-19 Vaccine In Trials Benzinga
Apr-05-21 05:59PM	UPDATE 1-Novavax starts allowing participants on placebo to get COVID-19 vaccine in trials Reuters
04:59PM	Novavax Initiates COVID-19 Vaccine Clinical Trial Crossover PR Newswire
04:31PM	Novavax to expand COVID-19 vaccine trials to children, teens MarketWatch
04:05PM	Novavax Initiates COVID-19 Vaccine Clinical Trial Crossover PR Newswire
04:05PM	Novavax Initiates COVID-19 Vaccine Clinical Trial Crossover CNW Group
02:06PM	Travel boom poses threat to COVID-19 recovery: Doctor Yahoo Finance Video
01:58PM	10 Best Biotech Stocks To Buy For 2021 Insider Monkey
01:23PM	JPMorgan Investor Survey Cites Moderna, Novavax as Ripe to Fall Bloomberg
11:40AM	Moderna, Novavax Make JPMorgan Short Pick List TheStreet.com
08:50AM	Novavax CEO Stan Erck to Participate in Longwood Healthcare Leaders Meeting PR Newswire
08:32AM	Is the Options Market Predicting a Spike in Novavax (NVAX) Stock? Zacks
05:37AM	Vaccine Stocks Checkup: Johnson & Johnson, Pfizer Update TheStreet.com
02:05AM	Covid-19 Vaccine Update And Outlook Amid New Variants, Hiccups For Some Vaccine Developers Investor's Business Daily Video
Apr-03-21 06:10AM	This Vaccine Stock Is a Money Machine in the Making Motley Fool
Apr-01-21 02:46PM	Quidel issued first emergency use authorization by FDA for a COVID-19 antigen test Yahoo Finance Video
02:07PM	How Bidens momentous rescue plan helps older Americans: NCOA President Yahoo Finance Video
01:46PM	Layers of mitigation against the virus remains critical: Doctor Yahoo Finance Video
10:33AM	Novavax's Vaccine Data Keeps Getting Better Motley Fool
08:58AM	Poland's Mabion aims to produce Novavax vaccine for Europe from Q3 Reuters
Mar-31-21 01:42PM	Pfizer vaccine 100% effective in 12 to 15 year olds: Study Yahoo Finance Video
06:04AM	Could Novavax Be Too Late to the Party to Win in the U.S. COVID Vaccine Market? Motley Fool
06:00AM	Here's Why The Best Is Yet to Come for Novavax Motley Fool
Mar-30-21 05:45PM	Novavax (NVAX) Stock Moves -0.25%: What You Should Know Zacks
03:15PM	Pandemic led to aggressive adoptions of technology in sports: Teamworks CEO Yahoo Finance Video
01:44PM	The Rockefeller Foundation is teaming up with COVID-19 testing companies to reopen schools safely Yahoo Finance Video
01:27PM	We can vaccinate our way out of this phase of the pandemic: Doctor Yahoo Finance Video
10:44AM	Why the COVID superhero villain tug-of-war will be an eternal battle Yahoo Finance Video
10:40AM	Biotech emerges as 'superhero' of global pandemic Yahoo Finance
Mar-29-21 08:55PM	Novavaxs Production Problems Are Overblown, Says Analyst TipRanks
08:48PM	PRESS DIGEST- Financial Times - March 30 Reuters
04:20PM	CDC Head Expresses Sense Of 'Impending Doom' Despite New Vaccine Study Investor's Business Daily
04:02PM	GSK to support manufacture of Novavax' COVID-19 vaccine PR Newswire
02:40PM	Glaxo To Fill About 60M Novavax COVID-19 Shots For Britain Benzinga
02:10PM	UPDATE 1-GSK to fill up to 60 mln Novavax vaccine doses for Britain Reuters
02:05PM	One dose of Pfizer or Moderna vaccine is 80% effective: CDC Yahoo Finance Video
12:53PM	GlaxoSmithKline Will Help Manufacture Novavaxs Covid-19 Vaccine for U.K. Barrons.com
12:00PM	GSK to fill up to 60 mln Novavax vaccine doses for Britain Reuters
07:55AM	Moderna vaccine to arrive in U.K. imminently as India starts testing Novavax inoculation MarketWatch
05:35AM	Buy-the-Dip Candidates: ViacomCBS and Discovery TheStreet.com
Mar-28-21 08:00PM	GSK to help manufacture 60m doses of Novavax Covid vaccine in UK Financial Times
06:25AM	Is Novavax a Buy? Motley Fool
06:01AM	3 Top Biotech Stocks to Buy Right Now Motley Fool

Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate. It is also developing RSV F vaccine that is in Phase II clinical trial for older adults (60 years and older), as well as that is in Phase I clinical trial for pediatrics. In addition, the company develops vaccine candidates for the protection against middle east respiratory syndrome, as well as that is in preclinical work associated with severe acute respiratory syndrome; and ebola virus glycoprotein vaccine candidate, as well as COVID-19 vaccine for variant strain. It has a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of NVX-CoV2373, a COVID-19 vaccine candidate. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Trizzino John	EVP, Chief Commercial Officer	Apr 07	Sale	178.03	191	34,004	287	Apr 07 05:09 PM
Trizzino John	EVP, Chief Commercial Officer	Apr 05	Option Exercise	34.01	3,404	115,771	3,308	Apr 07 05:09 PM
Trizzino John	EVP, Chief Commercial Officer	Apr 05	Sale	190.10	3,021	574,292	287	Apr 07 05:09 PM
Herrmann John A III	EVP, Chief Legal Officer	Mar 26	Option Exercise	14.82	2,894	42,886	3,169	Mar 30 06:10 PM
Herrmann John A III	EVP, Chief Legal Officer	Mar 26	Sale	186.80	2,894	540,609	275	Mar 30 06:10 PM
YOUNG JAMES F	Director	Mar 25	Option Exercise	8.96	47,500	425,438	57,500	Mar 25 06:41 PM
YOUNG JAMES F	Director	Mar 23	Option Exercise	46.00	10,000	460,000	20,000	Mar 25 06:41 PM
YOUNG JAMES F	Director	Mar 23	Sale	228.22	10,000	2,282,231	10,000	Mar 25 06:41 PM
MCMANUS MICHAEL A JR	Director	Mar 19	Sale	220.78	4,000	883,110	5,951	Mar 23 05:33 PM
Glenn Gregory M	President, R&D	Mar 17	Sale	218.86	2,423	530,304	2,811	Mar 17 06:35 PM
Glenn Gregory M	President, R&D	Mar 15	Option Exercise	109.95	10,531	1,157,843	8,523	Mar 17 06:35 PM
EVANS GARY C	Director	Mar 15	Option Exercise	19.52	24,500	478,330	40,599	Mar 17 06:36 PM
EVANS GARY C	Director	Mar 15	Sale	211.21	24,500	5,174,536	16,099	Mar 17 06:36 PM
Glenn Gregory M	President, R&D	Mar 15	Sale	198.60	5,712	1,134,400	2,811	Mar 17 06:35 PM
Trizzino John	EVP, Chief Commercial Officer	Mar 09	Sale	168.09	190	31,937	287	Mar 09 07:38 PM
Trizzino John	EVP, Chief Commercial Officer	Mar 05	Option Exercise	14.73	3,404	50,148	3,308	Mar 09 07:38 PM
Trizzino John	EVP, Chief Commercial Officer	Mar 05	Sale	163.46	3,021	493,824	287	Mar 09 07:38 PM
Herrmann John A III	EVP, Chief Legal Officer	Feb 26	Option Exercise	14.82	2,895	42,892	3,170	Mar 02 05:37 PM
Herrmann John A III	EVP, Chief Legal Officer	Feb 26	Sale	225.48	2,895	652,759	275	Mar 02 05:37 PM
Glenn Gregory M	President, R&D	Feb 18	Sale	269.57	2,434	656,134	2,811	Feb 18 06:59 PM
Glenn Gregory M	President, R&D	Feb 16	Option Exercise	13.16	10,531	138,577	8,523	Feb 18 06:55 PM
Glenn Gregory M	President, R&D	Feb 16	Sale	282.71	5,712	1,614,812	2,811	Feb 18 06:55 PM
Trizzino John	EVP, Chief Commercial Officer	Feb 09	Sale	324.50	194	62,953	287	Feb 09 07:40 PM
Trizzino John	EVP, Chief Commercial Officer	Feb 05	Option Exercise	14.73	3,406	50,160	3,309	Feb 09 07:40 PM
Trizzino John	EVP, Chief Commercial Officer	Feb 05	Sale	290.46	3,022	877,766	287	Feb 09 07:40 PM
Herrmann John A III	EVP, Chief Legal Officer	Feb 01	Option Exercise	18.15	15,022	272,724	15,297	Feb 03 05:37 PM
Herrmann John A III	EVP, Chief Legal Officer	Feb 01	Sale	241.50	15,022	3,627,789	275	Feb 03 05:37 PM
Trizzino John	EVP, CMO and CBO	Jan 07	Sale	124.17	506	62,830	287	Jan 07 07:08 PM
Trizzino John	EVP, CMO and CBO	Jan 05	Option Exercise	18.63	13,756	256,243	17,694	Jan 07 07:08 PM
Trizzino John	EVP, CMO and CBO	Jan 05	Sale	112.00	17,407	1,949,522	287	Jan 07 07:08 PM
YOUNG JAMES F	Director	Dec 31	Option Exercise	51.27	11,000	564,000	11,000	Jan 05 05:38 PM
DOUGLAS RICHARD	Director	Dec 31	Option Exercise	50.00	1,000	50,000	28,500	Jan 05 05:42 PM
YOUNG JAMES F	Director	Dec 31	Sale	113.09	11,000	1,244,014	0	Jan 05 05:38 PM
Erck Stanley C	President and CEO	Nov 16	Option Exercise	37.14	52,317	1,942,801	72,811	Nov 18 06:09 PM
Erck Stanley C	President and CEO	Nov 16	Sale	90.65	52,316	4,742,667	20,495	Nov 18 06:09 PM
Erck Stanley C	President and CEO	Oct 01	Sale	108.56	2	217	20,494	Oct 01 05:39 PM
Trizzino John	EVP, CBO and CFO	Sep 30	Sale	110.22	2,250	248,002	5,087	Oct 01 05:40 PM
Erck Stanley C	President and CEO	Sep 30	Sale	110.23	12,231	1,348,200	20,496	Oct 01 05:39 PM
Erck Stanley C	President and CEO	Sep 29	Sale	107.80	4,112	443,267	32,727	Sep 30 09:27 PM
Herrmann John A III	EVP, Chief Legal Officer	Sep 29	Sale	107.31	18,029	1,934,667	275	Sep 30 09:30 PM
Glenn Gregory M	President, R&D	Sep 29	Sale	107.02	19,949	2,134,844	1,561	Sep 30 09:29 PM
Trizzino John	EVP, CBO and CFO	Sep 29	Sale	107.29	18,321	1,965,630	7,337	Sep 30 09:28 PM
Trizzino John	EVP, CBO and CFO	Sep 28	Option Exercise	5.95	29,600	176,120	53,008	Sep 30 09:28 PM
Erck Stanley C	President and CEO	Sep 28	Option Exercise	5.95	50,000	297,500	74,606	Sep 30 09:27 PM
Herrmann John A III	EVP, Chief Legal Officer	Sep 28	Option Exercise	5.95	24,750	147,262	43,054	Sep 30 09:30 PM
Glenn Gregory M	President, R&D	Sep 28	Option Exercise	5.95	25,000	148,750	46,510	Sep 30 09:29 PM
Erck Stanley C	President and CEO	Sep 28	Sale	110.30	25,000	2,757,456	36,839	Sep 30 09:27 PM
Glenn Gregory M	President, R&D	Sep 28	Sale	110.30	25,000	2,757,456	21,510	Sep 30 09:29 PM
Trizzino John	EVP, CBO and CFO	Sep 28	Sale	110.30	25,000	2,757,456	25,658	Sep 30 09:28 PM
Herrmann John A III	EVP, Chief Legal Officer	Sep 28	Sale	110.30	24,750	2,729,879	18,304	Sep 30 09:30 PM
EVANS GARY C	Director	Aug 18	Option Exercise	31.02	10,500	325,700	332,479	Aug 20 06:09 PM
Glenn Gregory M	President, R&D	Aug 18	Option Exercise	33.56	55,921	1,876,525	57,760	Aug 20 06:14 PM
Herrmann John A III	EVP, Chief Legal Officer	Aug 18	Option Exercise	53.82	46,242	2,488,613	46,517	Aug 20 06:20 PM
MCMANUS MICHAEL A JR	Director	Aug 18	Option Exercise	27.60	8,000	220,800	17,951	Aug 20 06:22 PM
Trizzino John	EVP, CBO and CFO	Aug 18	Option Exercise	50.95	42,788	2,179,986	47,875	Aug 20 06:25 PM
Trizzino John	EVP, CBO and CFO	Aug 18	Sale	148.78	42,788	6,366,182	5,087	Aug 20 06:25 PM
MCMANUS MICHAEL A JR	Director	Aug 18	Sale	146.00	8,000	1,168,000	9,951	Aug 20 06:22 PM
Herrmann John A III	EVP, Chief Legal Officer	Aug 18	Sale	144.33	46,242	6,673,982	275	Aug 20 06:20 PM
Glenn Gregory M	President, R&D	Aug 18	Sale	145.20	55,921	8,119,860	1,839	Aug 20 06:14 PM
EVANS GARY C	Director	Aug 18	Sale	150.44	10,500	1,579,620	321,979	Aug 20 06:09 PM
Glenn Gregory M	President, R&D	Jun 18	Option Exercise	42.20	16,749	706,808	18,588	Jun 22 05:29 PM
Glenn Gregory M	President, R&D	Jun 18	Sale	59.53	16,749	997,103	1,839	Jun 22 05:29 PM
YOUNG JAMES F	Director	Jun 03	Buy	48.83	1,500	73,245	1,500	Jun 05 05:04 PM
Herrmann John A III	SVP, General Counsel	May 18	Option Exercise	26.19	12,961	339,448	7,774	May 20 04:35 PM
Herrmann John A III	SVP, General Counsel	May 18	Sale	49.44	12,961	640,792	275	May 20 04:35 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience